Covered recipient · General Payments record
GABRIELLE M ADAMS
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,354.87
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $424.63 | 26 |
| Education | $117.16 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $264.10 | 17 |
| Janssen Biotech, Inc. | $114.56 | 2 |
| Phathom Pharmaceuticals, Inc. | $37.37 | 2 |
| Olympus America Inc. | $32.78 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $25.26 | 1 |
| Celgene Corporation | $23.96 | 1 |
| Celltrion USA Inc. | $18.16 | 1 |
| PFIZER INC. | $14.69 | 1 |
| Endogastric Solutions, Inc | $10.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.30 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173880 | CMS |
| ABBVIE INC. | $21.54 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173882 | CMS |
| ABBVIE INC. | $4.78 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173884 | CMS |
| ABBVIE INC. | $10.26 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173886 | CMS |
| ABBVIE INC. | $9.86 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173888 | CMS |
| ABBVIE INC. | $10.40 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173890 | CMS |
| ABBVIE INC. | $9.07 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173892 | CMS |
| ABBVIE INC. | $28.37 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173894 | CMS |
| ABBVIE INC. | $15.84 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173896 | CMS |
| ABBVIE INC. | $29.39 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173898 | CMS |
| ABBVIE INC. | $6.94 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173900 | CMS |
| ABBVIE INC. | $9.27 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173902 | CMS |
| ABBVIE INC. | $8.72 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173904 | CMS |
| ABBVIE INC. | $25.28 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173906 | CMS |
| ABBVIE INC. | $25.62 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173908 | CMS |
| ABBVIE INC. | $6.68 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173910 | CMS |
| ABBVIE INC. | $20.78 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103173912 | CMS |
| Celgene Corporation | $23.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101153133 | CMS |
| Celltrion USA Inc. | $18.16 | 09/05/2024 | Education | Undisputed | 01/23/2026 | 1075847829 | CMS |
| Endogastric Solutions, Inc | $10.91 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144677122 | CMS |
| Janssen Biotech, Inc. | $15.56 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078385108 | CMS |
| Janssen Biotech, Inc. | $99.00 | 06/11/2024 | Education | Undisputed | 01/23/2026 | 1078383837 | CMS |
| Olympus America Inc. | $16.74 | 01/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108472148 | CMS |
| Olympus America Inc. | $16.04 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108472150 | CMS |
| PFIZER INC. | $14.69 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131183810 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.94 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151032266 | CMS |
| Phathom Pharmaceuticals, Inc. | $18.43 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151032268 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $25.26 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153528753 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.